CMS Unveils Enhanced “Drug Dashboards” to Increase Transparency on Drug Prices

The Centers for Medicare & Medicaid Services (CMS) released a redesigned version of the Drug Spending Dashboards, which include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices. The dashboards are interactive online tools that allow patients, clinicians, researchers, and the public to understand trends in drug spending with data reported for both Medicare and Medicaid. 

Additional information can be obtained at